$1,099.00
This KOL survey answers key questions about current immunotherapy treatments and future trends in the immuno-oncology space.
This KOL survey answers key questions about current immunotherapy treatments and future trends in the immuno-oncology space.
In partnership with Skipta, we performed an 18-question survey of 26 oncologists practicing throughout the US.
All 26 respondents included in this survey are members of Skipta’s Oncology Nation community and attended the 2018 American Society of Clinical Oncology (ASCO) annual meeting, where numerous trial results and updated analyses on immunotherapies were presented.
The survey includes questions derived from ASCO presentations, as well as general immunotherapy-focused questions surrounding important mechanisms of action, medicines, and general practice within the immuno-oncology field.
Survey Questions:
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!